Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced the launch of its first ODM system designed specifically for veterinary use which has generated £15,000 on release from the first sale of a system to a leading continental Europe Veterinary University.
The ODMV+ monitor is based on the CardioQ-ODM+ platform and is accessed via the specially designed K9 probes. These probes are designed for smaller animals such as dogs and cats and allow multiple uses for a period of 30 days, providing an attractive per case billing model for veterinary practices.
Deltex is planning the marketing launch of the new system for the annual meeting of the International Veterinary Emergency and Critical Care Symposium (‘IVECCS’) in Nashville, Tennessee in September 2017. In the meantime it is promoting the system to existing contacts.
Ewan Phillips, Deltex Medical Group plc Chief Executive, commented: “We are delighted to have made our first sale of the ODMV+ system simultaneously with its release. ODM is ideally suited for use in animals who tend to have high degrees of haemodynamic instability during surgery and in critical care.
“We have a small number of other customers already interested in the system and expect to generate further interest after the market launch at IVECCS at which there will be presentations from a number of experts who have been working with Deltex on developing the ODMV+. Our medium term goal is to develop the veterinary business to a stage where it is sold through specialist distributors.”
